Personally I think these sector rotation models are useful for identifying sector performance anomalies.
Might be getting sick of me pounding the healthcare sector table, but to me this is where an anomaly lies.
Consumer staples have been pushed to highs w/yields of 1, 2-3%, Utilities again have been pushed up, but are still yielding near 4%(I suspect they can hold these levels for awhile longer)....and wedged in the middle is healthcare, with dismal performance compared to the other 2. Imo this is a result of outside factors, election campaign rhetoric, Obama seeking an undeserved legacy, the senate etc.
I'd like to add another pharma stock, any suggestions out there? Looking at LLY from a technical standpoint.
Currently holding ABBV ,MRK
and VGHCX
VGHCX top 10:
Top 10 Holdings (41.18% of Total Assets) CompanySymbol% AssetsYTD Return %|
| Allergan plc Ordinary Shares | AGN | 6.56 | N/A | | Bristol-Myers Squibb Company Co | BMY | 6.09 | N/A | | UnitedHealth Group Incorporated | UNH | 5.28 | N/A | | Merck & Company, Inc. Common St | MRK | 5.10 | N/A | | Eli Lilly and Company Common St | LLY | 3.97 | N/A | | AstraZeneca PLC | AZNCF.L | 3.84 | N/A | | Medtronic plc. Ordinary Shares | MDT | 2.96 | N/A | | Mylan N.V. | MYL | 2.51 | N/A | | McKesson Corporation Common Sto | MCK | 2.50 | N/A | | Regeneron Pharmaceuticals, Inc. | REGN | 2.37 | N/ |
|
|
